BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35746617)

  • 1. Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread.
    Holtappels R; Podlech J; Freitag K; Lemmermann NA; Reddehase MJ
    Viruses; 2022 May; 14(6):. PubMed ID: 35746617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.
    Holtappels R; Becker S; Hamdan S; Freitag K; Podlech J; Lemmermann NA; Reddehase MJ
    PLoS Pathog; 2023 Nov; 19(11):e1011643. PubMed ID: 37972198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
    Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
    Front Immunol; 2021; 12():694588. PubMed ID: 34489940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.
    Holtappels R; Schader SI; Oettel O; Podlech J; Seckert CK; Reddehase MJ; Lemmermann NAW
    Front Cell Infect Microbiol; 2020; 10():157. PubMed ID: 32351904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
    Lemmermann NA; Reddehase MJ
    Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells.
    Hamdan S; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2023 Apr; 212(2):153-163. PubMed ID: 35364731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time".
    Reddehase MJ; Lemmermann NAW
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.
    Ebert S; Podlech J; Gillert-Marien D; Gergely KM; Büttner JK; Fink A; Freitag K; Thomas D; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2012 Nov; 201(4):527-39. PubMed ID: 22972232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance.
    Holtappels R; Lemmermann NA; Podlech J; Ebert S; Reddehase MJ
    Front Immunol; 2016; 7():232. PubMed ID: 27379095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cytomegalovirus immune evasion identifies direct antigen presentation as the predominant mode of CD8 T-cell priming during immune reconstitution after hematopoietic cell transplantation.
    Holtappels R; Büttner JK; Freitag K; Reddehase MJ; Lemmermann NA
    Front Immunol; 2024; 15():1355153. PubMed ID: 38426094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
    Fink A; Lemmermann NA; Gillert-Marien D; Thomas D; Freitag K; Böhm V; Wilhelmi V; Reifenberg K; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2012 Nov; 201(4):513-25. PubMed ID: 22961126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.
    Böhm V; Podlech J; Thomas D; Deegen P; Pahl-Seibert MF; Lemmermann NA; Grzimek NK; Oehrlein-Karpi SA; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2008 Jun; 197(2):135-44. PubMed ID: 18340461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus-Associated Inhibition of Hematopoiesis Is Preventable by Cytoimmunotherapy With Antiviral CD8 T Cells.
    Renzaho A; Podlech J; Kühnapfel B; Blaum F; Reddehase MJ; Lemmermann NAW
    Front Cell Infect Microbiol; 2020; 10():138. PubMed ID: 32373544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation.
    Reddehase MJ
    Front Immunol; 2016; 7():294. PubMed ID: 27540380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.
    Holtappels R; Böhm V; Podlech J; Reddehase MJ
    Med Microbiol Immunol; 2008 Jun; 197(2):125-34. PubMed ID: 18343947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
    Jeitziner SM; Walton SM; Torti N; Oxenius A
    Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune control in the absence of immunodominant epitopes: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
    Ebert S; Lemmermann NA; Thomas D; Renzaho A; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2012 Nov; 201(4):541-50. PubMed ID: 22976556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.
    Gezinir E; Podlech J; Gergely KM; Becker S; Reddehase MJ; Lemmermann NAW
    Front Cell Infect Microbiol; 2020; 10():279. PubMed ID: 32582572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.
    Holtappels R; Simon CO; Munks MW; Thomas D; Deegen P; Kühnapfel B; Däubner T; Emde SF; Podlech J; Grzimek NK; Oehrlein-Karpi SA; Hill AB; Reddehase MJ
    J Virol; 2008 Jun; 82(12):5781-96. PubMed ID: 18367531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection.
    Podlech J; Holtappels R; Pahl-Seibert MF; Steffens HP; Reddehase MJ
    J Virol; 2000 Aug; 74(16):7496-507. PubMed ID: 10906203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.